Jon Coleman - May 22, 2025 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP, Chief Commercial Officer
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Jon Coleman
Stock symbol
DXCM
Transactions as of
May 22, 2025
Transactions value $
$0
Form type
4
Date filed
5/27/2025, 04:12 PM
Previous filing
Mar 31, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coleman Jon EVP, Chief Commercial Officer 6430 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Jon Coleman 2025-05-27 0001442689

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0 +68.7K $0.00 68.7K May 22, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in four equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.